跳至主要内容
临床试验/NCT05904899
NCT05904899
暂停
不适用

An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 40 人2023年8月1日
适应症Cancer

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cancer
发起方
M.D. Anderson Cancer Center
入组人数
40
试验地点
1
主要终点
Quality of Life questionnaires (QOL)
状态
暂停
最后更新
上个月

概览

简要总结

To understand the experience of patients receiving care in the Care and Monitoring at Home program at MD Anderson. Researchers intend to use this information to study and possibly improve the hospital care at home program.

详细描述

OBJECTIVES Primary Objectives The objective of this observational study is to assess the feasibility of providing hospital substitution hospital level care in the home for patients with cancer through the CaMH Program. Our primary gauge of feasibility will be a care escalation rate of \<20%, defined as the proportion of patients who initiate care in our HaH program but are transferred back to the inpatient setting to complete the care episode. This threshold is consistent with the published literature.15 In addition, a "feasible" designation will require a median score \> 3 on each of three post-discharge survey implementation measures - the Feasibility of Implementation Measure, Acceptability of Implementation Measure, and Intervention Appropriateness Measure. Secondary Objectives Secondary objectives will include patient experience and perception about CaMH, length of stay, rate of clinical adverse events during CaMH (falls, pressure ulcers, medication errors) and 30-days after discharge, 7-day readmission, 30-day readmission, and 30-day emergency department visit rate. (Note, the aforementioned adverse events could occur as a result of participation in CaMH. However, minimal adverse events are expected a result of participation in this observational study (see adverse events below)). A patient will be considered to have an ER visit or hospital readmission if these events are documented in the medical record OR the patient reports the event on the survey.

注册库
clinicaltrials.gov
开始日期
2023年8月1日
结束日期
2026年12月31日
最后更新
上个月
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Participants will be eligible for enrollment in this study if they have accepted enrollment in CaMH. No patients will be excluded if they are enrolled in CaMH.
  • Cognitively impaired adults will be able to participate in the study if an adults proxy provides informed consent and completes survey materials on their behalf.

排除标准

  • \- Children and pregnant women will not be enrolled in the CaMH program, and therefore not eligible for this study.

结局指标

主要结局

Quality of Life questionnaires (QOL)

时间窗: through study completion; an average of 1 year

研究点 (1)

Loading locations...

相似试验